Cardiogen Research Guide: Cardiac Peptide Bioregulator (Ala-Glu-Asp-Arg)
Cardiogen is a short tetrapeptide bioregulator (Ala-Glu-Asp-Arg) from the Khavinson peptide class, studied for cardiac cell gene-expression and cardiovascular-aging research.
What is Cardiogen?
Cardiogen is a short synthetic tetrapeptide (Ala-Glu-Asp-Arg) from the Khavinson class of peptide bioregulators — a research family developed in Russian gerontology literature that emphasizes tissue-specific transcriptional modulation via ultra-short peptides.
Mechanism of action
Cardiogen is proposed to enter cardiac cell nuclei and bind promoter regions of cardiomyocyte-associated genes, modulating expression of transcription factors involved in differentiation, mitochondrial biogenesis, and extracellular matrix maintenance in heart tissue.
It is studied alongside SS-31 (mitochondrial cardiolipin stabilization) and Epithalon (telomerase/pineal axis) as complementary tools for cardiovascular-aging research programs.
Sourcing & purity
Research-grade material should be ≥99% pure by HPLC with peptide content confirmed via mass spectrometry. Redline Bio material ships with batch documentation; independent third-party COAs are published on the lab reports page as testing returns.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
What is Cardiogen?
Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg) belonging to the Khavinson family of short peptide bioregulators, developed and studied primarily for cardiac tissue research.
Mechanism?
It is proposed to enter cell nuclei and interact with promoter regions of cardiomyocyte-associated genes, modulating transcription factors linked to cardiac cell differentiation, mitochondrial function, and connective-tissue remodeling.
How is it typically studied?
Cardiogen is studied in cardiovascular aging models, myocardial gene-expression research, and alongside other Khavinson bioregulators (Epithalon, Prostamax, Vesugen) as a tissue-specific probe.